Question 383 · LEK · Fluid and electrolyte disorders
Hypercalcemia related to malignancy:
- A. is most frequent in patients with chronic myeloid leukaemia.
- B. may be related to parathormone secretion.
- C. should always be treated with oral biphosphonates.
- D. answers A and B are correct.
- E. answers A, B, and C are correct.
Hint
Think about PTH-like mediators released by tumours, which cancers typically cause hypercalcaemia and the route of bisphosphonate therapy.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.